Isradipine
- Isradipine in the treatment of hypertension: a clinical profile
A new calcium channel blocker is safe, well tolerated, and has long-term antihypertensive efficacy regardless of age or race, with no adverse effects on lipids, carbohydrate tolerance, or renal function.